Table 2.
Genetic Characteristics of Study Subjects and Family Members
| ID | Sex | Ancestry |
WDR45 Mutations Identified |
Mutation Status of Family Members |
|||
|---|---|---|---|---|---|---|---|
| cDNA (RefSeq NM_007075.3) | Protein (RefSeq NP_009006) | Mother | Father | Sibling (n) | |||
| 60251 | F | German, Irish, English, Austrian | c.1007_1008del | p.Tyr336Cysfs∗5 | WT | WT | WT (1) |
| 63700 | F | German, Sioux, Cherokee | c.38G>C | p.Arg13Proa | WT | WT | WT (2) |
| 63701 | F | German, French, Irish | c.-1_5del | p.Met1? | WT | N/A | N/A |
| 63702 | F | African American | c.293T>C | p.Leu98Pro | WT | N/A | WT (1) |
| 63703 | F | African American | c.476del | p.Leu159Argfs∗2 | N/A | N/A | N/A |
| 63704 | F | Hispanic, Puerto Rican | c.19C>T | p.Arg7∗ | N/A | N/A | N/A |
| 63705 | F | Romanian, French | c.56-1G>A | splicing defect | N/A | N/A | N/A |
| 63706 | F | German, Irish, English | c.700C>T | p.Arg234∗ | WT | N/A | WT (4) |
| 63707 | F | unknown | c.400C>T | p.Arg134∗ | WT | WT | WT (3) |
| 63708 | M | German, Irish, Scottish | c.228_229del | p.Glu76Aspfs∗38 | WT | WT | N/A |
| 63709 | F | Italian, northern European, Native American | c.405_409del | p.Lys135Asnfs∗2 | N/A | N/A | N/A |
| 63711 | F | Dutch | c.359dup | p.Lys121Glufs∗18 | WT | WT | WT (4) |
| 63712 | F | Scottish, Irish | c.830+1G>A | splicing defect | WT | WT | N/A |
| 49841 | M | German | c.19dup | p.Arg7Profs∗64 | N/A | N/A | N/A |
| 411-201 | F | Italian | c.235+1G>A | splicing defect | WT | WT | N/A |
| HH56 | F | unknown | c.1007_1008del | p.Tyr336Cysfs∗5 | WT | WT | N/A |
| HH84 | F | unknown | c.694_703del | p.Leu232Alafs∗53 | WT | WT | N/A |
| NBIA10 | F | Pakistani | c.183C>A | p.Asn61Lys | WT | WT | N/A |
| 463 | M | English | c.1025_1034delinsACATATTT | p.Gly342Aspfs∗12 | N/A | N/A | N/A |
| 152 | F | unknown | c.55+1G>C | splicing defect | WT | WT | WT (1) |
Numbers in parentheses indicate the amount of tested siblings of the proband. The following abbreviations are used: F, female; M, male; WT, wild-type; and N/A, not available.
This alteration is predicted to cause skipping of exon 3 and usage of an alternate start methionine at position 25.